Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
4.7 (150 items)
Limited Time SaleUS$103.11 cheaper than the new price!!
Free cash-on-delivery fees for purchases over $99
Product details
| Management number | 233567601 | Release Date | 2026/06/27 | List Price | US$68.74 | Model Number | 233567601 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Resistance to chemotherapy, and especially multi-drug resistance, represents a significant barrier to the successful treatment of cancer. This multi-author volume brings together a wide range of up-to-date reviews on different aspects of our knowledge of drug-resistance mechanisms, written by experts in the different areas. Particular attention is paid to recently discovered mechanisms relating to oncogene expression and in particular to proteins involved in regulation and execution of apoptosis. Other important topics covered include DNA repair, topoisomerases, cell cycle control, oxygenation and vascularisation of tumours, LRP, intermediate filament proteins and low-level resistance. Recent developments in understanding the role of efflux pumps (P-170, MRP) in multi-drug resistance are also reviewed. This book will be useful to clinicians and scientists working in the areas of chemotherapy, drug resistance, DNA repair and apoptosis research. Read more
| ISBN10 | 0792352726 |
|---|---|
| ISBN13 | 978-0792352723 |
| Edition | Reprinted from CYTECHNOLOGY, 27:1-3, 1998 |
| Language | English |
| Publisher | Springer |
| Dimensions | 7 x 0.81 x 10 inches |
| Item Weight | 1.85 pounds |
| Print length | 355 pages |
| Publication date | January 31, 1999 |
Bestseller ranking
Oncology
Customers who viewed this product also viewed
Asia
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form